Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00907309 · ClinicalTrials.gov registry record · Phase 1
Dental and Medical Office iMET to Reduce Teen Tobacco, Alcohol, and Drug Use
A Phase 1 study of Alcohol Abuse and Drug Abuse, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 121
- Enrollment target
- 1
- Study location
NCT00907309: Completed Phase 1 study of Alcohol Abuse and Drug Abuse, sponsored by Boston Children's Hospital.
NCT00907309 is a Phase 1 study of Alcohol Abuse and Drug Abuse that has completed, run by Boston Children's Hospital. The registered enrollment target is 121 participants, below the 710-participant average among 46 other Alcohol Abuse trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00907309, a Phase 1 study of Alcohol Abuse and Drug Abuse, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 121 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the project is to improve adolescent behavioral counseling services in healthcare settings with a new Internet/Intranet-based Motivational Enhancement Therapy (iMET) intervention that targets the use of tobacco, alcohol, and other drugs.
Conditions Studied
Interventions
- BEHAVIORAL iMET
- BEHAVIORAL iMET/TE
Study Locations (1)
Massachusetts
- Children's Hospital Boston - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2010-09 |
| Est. Completion | 2012-09 |
| Phase | Phase 1 |
What the finished NCT00907309 record still lists
NCT00907309 is an interventional study that assigns participants to a tested intervention. The registered 121 participants enrollment target is mid-sized for trials with a published cap, below the 710-participant average among 46 other Alcohol Abuse trials with a reported enrollment target (83% lower).
The record links to 3 conditions, with Alcohol Abuse appearing as the primary indexed condition, and to 2 interventions - of which iMET is the first listed.
NCT00907309 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00907309 about?
NCT00907309 is a clinical study titled "Dental and Medical Office iMET to Reduce Teen Tobacco, Alcohol, and Drug Use". The purpose of the project is to improve adolescent behavioral counseling services in healthcare settings with a new Internet/Intranet-based Motivational Enhancement Therapy (iMET) intervention that targets the use of tobacco, alcohol, and other drugs.
What is the current status of trial NCT00907309?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 121 participants. The study started on 2010-09. Estimated completion is 2012-09.
What conditions does trial NCT00907309 study?
This clinical trial studies the following conditions: Alcohol Abuse, Drug Abuse, Use; Tobacco, Harmful.
What interventions are being tested in trial NCT00907309?
The interventions under investigation include: iMET (BEHAVIORAL), iMET/TE (BEHAVIORAL).
Who is sponsoring clinical trial NCT00907309?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00907309 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00907309's enrollment target sits among peer trials
121 26th of 46 higher than 21 of 46 other Alcohol Abuse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home
COMPLETED · Phase 1
-
Examining Alcohol Consumption, Perceptions, and User Experience of Alcohol Moderation Strategies
COMPLETED · Phase 1
-
Family Check-Up for Adolescents and Siblings
COMPLETED · Phase 1
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
-
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03476681 · 121 participants · Phase 1
Study of NEO-201 in Solid Tumors Expansion Cohorts
- NCT04655118 · 121 participants · Phase 2
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
- NCT04676802 · 121 participants · Phase 2
Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone
- NCT05169515 · 121 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia